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Abstract 
Background: The cell-cycle inhibitor  p57kip2 plays a critical role in mammalian development by coordinating 
cell proliferation and differentiation in many cell types.  p57kip2 expression is finely regulated by several epigenetic 
mechanisms, including paternal imprinting. Kcnq1ot1, a long non-coding RNA (LncRNA), whose gene maps to the 
p57Kip2 imprinting domain, is expressed exclusively from the paternal allele and participates in the cis-silencing of the 
neighboring imprinted genes through chromatin-level regulation. In light of our previous evidence of a functional 
interaction between myogenic factors and imprinting control elements in the regulation of the maternal p57Kip2 allele 
during muscle differentiation, we examined the possibility that also Kcnq1ot1 could play an imprinting-independent 
role in the control of p57Kip2 expression in muscle cells.
Results: We found that Kcnq1ot1 depletion by siRNA causes the upregulation of the maternal and functional p57Kip2 
allele during differentiation, suggesting a previously undisclosed role for this LncRNA. Consistently, Chromatin Oligo-
affinity Precipitation assays showed that Kcnq1ot1 physically interacts not only with the paternal imprinting control 
region of the locus, as already known, but also with both maternal and paternal alleles of a novel p57Kip2 regula-
tory region, located intragenically and containing two binding sites for the muscle-specific factor MyoD. Moreover, 
chromatin immunoprecipitation assays after Kcnq1ot1 depletion demonstrated that the LncRNA is required for the 
accumulation of H3K27me3, a chromatin modification catalyzed by the histone-methyl-transferase EZH2, at the 
maternal p57kip2 intragenic region. Finally, upon differentiation, the binding of MyoD to this region and its physical 
interaction with Kcnq1ot1, analyzed by ChIP and RNA immunoprecipitation assays, correlate with the loss of EZH2 
and H3K27me3 from chromatin and with p57Kip2 de-repression.
Conclusions: These findings highlight the existence of an imprinting-independent role of Kcnq1ot1, adding new 
insights into the biology of a still mysterious LncRNA. Moreover, they expand our knowledge about the molecular 
mechanisms underlying the tight and fine regulation of p57Kip2 during differentiation and, possibly, its aberrant silenc-
ing observed in several pathologic conditions.
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Background
The p57Kip2 gene (also known as Cdkn1c and hereafter 
termed p57) encodes a member of the Cip/Kip family of 
the cyclin-dependent-kinase (CDK) inhibitors. p57 is a 
critical regulator of cell proliferation and differentiation 
during mammalian development and plays unique func-
tions respect to the other family members [1]. In addition 
to cell cycle, p57 also influences other cellular activities, 
such as cell migration, apoptosis and senescence [2, 3]. 
Consistent with its multiple roles in cellular and devel-
opmental processes, the abnormal function of p57 causes 
several types of growth-related diseases and cancer [4–7].
The regulation of p57 expression is the object of exten-
sive investigation. In fact, most of the human growth 
disorders related to p57 malfunction result from altered 
gene expression rather than from gene mutations. More-
over, since p57 is an imprinted gene, its transcriptional 
regulation represents a paradigmatic example of epige-
netic control of gene expression.
p57 maps to the growth-related Cdkn1c/Kcnq1 
imprinted domain, which spans about 1 Mb along the dis-
tal arm of chromosome 7 in mouse and the p15.5 region 
of chromosome 11 in human [8]. This domain includes 
10 protein-coding genes, including p57, which are 
expressed from the respective maternally derived alleles, 
and the non-protein-coding gene Kcnq1ot1 (Kcnq1 oppo-
site transcript 1), which is transcribed antisense to the 
protein-coding gene Kcnq1 into a regulatory long non-
coding RNA (LncRNA) from the paternally derived allele 
[9]. A number of strategies based on epigenetic mecha-
nisms cooperate to establish and maintain the silencing 
of the non-expressed p57 allele. An imprinting control 
region, KvDMR1 (Kv-differentially methylated region 
1), located about 150  kb downstream of p57, bears dif-
ferential epigenetic marks on the two parental alleles and 
harbors multiple and partially overlapping regulatory ele-
ments [10–12]. Among these elements, a CTCF-depend-
ent chromatin insulator and the promoter of Kcnq1ot1, 
which are both hypomethylated and consequently active 
on the paternal KvDMR1, have been clearly involved in 
establishing the cis-silencing of p57 and of the other pro-
tein-coding genes of the imprinted domain [10, 13–15].
Consistent with the critical importance of the proper 
p57 expression dosage, not only the paternal allele is 
ubiquitously and permanently silenced, but also the 
maternal allele is tightly and finely regulated during 
development and differentiation [16]. Our work in mus-
cle cells revealed that KvDMR1, in addition to control 
the silencing of the imprinted p57 paternal allele, is also 
involved in preventing the expression of the functional 
p57 maternal allele until differentiation occurs [17, 18]. In 
particular, in undifferentiated myoblasts, KvDMR1 par-
ticipates in a repressive long-range chromatin interaction 
with p57 promoter, mediated by CTCF. Upon differ-
entiation, the myogenic factor MyoD binds to specific 
target sequences adjacent to CTCF binding sites within 
KvDMR1. This interaction, which is prevented by the 
presence of repressive chromatin marks in myogenic cell 
types unable to express p57 [19], causes the disruption of 
the CTCF-mediated loop and the induction of maternal 
p57 expression.
Kcnq1ot1 is a macro LncRNA of about 90 kb, unspliced 
and exclusively localized in the nucleus [20]. Loss of 
paternal Kcnq1ot1, as a result of either promoter dele-
tion [21] or premature transcript termination [15, 21], is 
associated with loss of imprinting. However, the molecu-
lar mechanisms by which Kcnq1ot1 contributes to gene 
silencing are far from being clarified, in large part due 
to its high complexity, resulting from the enormous size 
and to the consequent difficulties in every experimen-
tal approach to its study. Kcnq1ot1 has been shown to 
coat specific chromatin regions along the Cdkn1c/Kcnq1 
domain [22–24]. The pattern and the extent of Kcnq1ot1-
chromatin interactions correlate with the accumulation 
of repressive histone modifications on the regulatory 
regions of imprinted genes and with their silencing [25, 
26]. This is at least in part explained by the property of 
Kcnq1ot1 to interact with histone methyltransferases, 
such as G9a and the Polycomb Repressive Complex 2 
(PRC2) components, recruiting them to its target genes 
to establish their imprinted status [23, 27]. Kcnq1ot1 also 
interacts with the DNA Methyl Transferase 1 (DNMT1), 
and this interaction is required for the accumulation of 
DNA methylation at the promoters of some imprinted 
genes and for the maintenance of their silencing [28, 29].
The molecular mechanisms by which Kcnq1ot1 asso-
ciates with non-overlapping target genes, spread over 
almost 1 Mb, are not clear. It is believed that LncRNAs 
can localize to specific DNA regions through affinity 
interactions with local factors, such as chromatin pro-
teins and transcription factors and/or through the estab-
lishment of physical contacts between distant genomic 
regions resulting from chromatin looping [30, 31]. 
Regarding Kcnq1ot1, it has been shown that the LncRNA 
itself participates in the establishment of higher order 
intra-chromosomal interactions [32]. Moreover, it is 
becoming increasingly apparent that LncRNAs, including 
Kcnq1ot1, can target specific DNA sequences by forming 
RNA–DNA triplexes [33].
Another unresolved question concerns the molecu-
lar mechanisms by which Kcnq1ot1, as well as other 
LncRNAs, associates with and organize the regulatory 
complexes recruited on its targets. It has been reported 
that a conserved 890  bp sequence, mapping at the 5’ of 
Kcnq1ot1 and termed silencing domain, is required for 
the interaction of the LncRNA with DNMT1 and for 
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its association with chromatin [28]. However, it is still 
unclear if this sequence mediates a direct or an indirect 
interaction of Kcnq1ot1 with chromatin and/or with 
DNMT1 or if it is involved in the formation of a crucial 
structure of the LncRNA.
Even less is known about the regulation of Kcnq1ot1 
activity. Kcnq1ot1 is expressed at relatively high levels 
in all tissues analyzed [9], but its pattern of chromatin 
binding and its ability to interact with histone modifying 
complexes are different between tissues [23]. This sug-
gests that the target specificity of Kcnq1ot1-mediated 
silencing can be modulated by additional, and likely com-
plex, regulatory interactions.
The little information available to date on the function 
of Kcnq1ot1 in p57 regulation concerns, almost exclu-
sively, the imprinting control. In light of our previous evi-
dence that some of the factors involved in the regulation 
of the paternal allele during imprinting, such as CTCF 
and KvDMR1, can be also involved in the regulation of 
the maternal allele during differentiation, we wanted 
to examine the possibility that Kcnq1ot1 could play an 
imprinting-independent role in the MyoD-dependent 
regulation of p57 during differentiation.
In the present work, we show that an additional level 
of transcriptional regulation of maternal p57 in muscle 
cells involves the functional interaction of Kcnq1ot1 with 
a novel and intragenic regulatory region of the p57 gene. 
This level of regulation implies the Kcnq1ot1-depend-
ent accumulation of the repressive histone modification 
H3K27me3 in undifferentiated cells and its loss upon 
differentiation, correlated with the interaction of MyoD 
with Kcnq1ot1 at the same region.
Results
Kcnq1ot1 depletion causes the upregulation of the p57 
maternal allele
We previously reported that repressive epigenetic 
changes at p57 promoter and KvDMR1 are involved in 
the transcriptional control of the gene during muscle dif-
ferentiation [18, 19, 34]. Since Kcnq1ot1, by recruiting 
chromatin modifiers, is capable to establish epigenetic 
marks at least on the paternal p57 allele [23], we asked 
whether the LncRNA could also mediate the epigenetic 
regulation of the maternal p57 allele in muscle cells. In 
light of the demonstrated ability of siRNAs and shRNAs 
to efficiently deplete nuclear transcripts [35], including 
Kcnq1ot1 [36–38], we performed a knockdown assay to 
assess the effects of Kcnq1ot1 depletion on p57 expres-
sion. Proliferating myoblasts were transfected with a 
Kcnq1ot1-targeting pool of small-interfering RNAs and a 
non-targeting pool as a control. Kcnq1ot1 depletion was 
verified through RT-qPCR assays. As shown in Fig.  1a, 
Kcnq1ot1 transcript levels were efficiently reduced 
respect to the control. The expression levels of p57 were 
analyzed by collecting samples 24  h after the shift to 
differentiation medium, a condition that allows MyoD 
activation and p57 induction. Interestingly, as shown 
in Fig.  1b, Kcnq1ot1 depletion correlates with a signifi-
cant increase of p57 expression. In contrast, the expres-
sion of p21, a related CDK inhibitor and a MyoD target 
as well [39], was not changed at all. Unexpectedly, even 
the expression of Kcnq1, which is overlapped in antisense 
orientation by Kcnq1ot1 [9, 40], was not increased by the 
depletion of the LncRNA, suggesting that the observed 
effect on gene expression is specific for p57.
Fig. 1 Kcnq1ot1 knockdown boosts p57 induction in differentiating myoblasts. a Proliferating C2.7 myoblasts were transfected with Kcnq1ot1 
siRNAs. After 24 h cells were collected to analyze Kcnq1ot1 levels by RT-qPCR in samples depleted for Kcnq1ot1 transcript (siKcnq1ot1) compared 
to the control (siCTR). Values, relative to those of Tbp RNA, are the mean ± SEM of three independent experiments. Statistical significance: p value 
< 0.01 (**); b RT-qPCR analysis of p57, p21 and Kcnq1 expression in siCTR and siKcnq1ot1-transfected cells 24 h after the shift to differentiation 
medium. Values, relative to those of Tbp RNA, are the mean ± SEM of three independent experiments. Statistical significance: p value < 0.001 (***)
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Since Kcnq1ot1 participates in the silencing of the 
imprinted p57 paternal allele, we asked whether the 
increased p57 expression, observed after Kcnq1ot1 deple-
tion, was due to loss of imprinting or rather to the upreg-
ulation of the active, maternal p57 allele. To investigate 
this issue, we took advantage of a muscle differentiation 
system based on the myogenic conversion of non-muscle 
cells by exogenous MyoD expression. This system gave us 
the opportunity to exploit mouse fibroblasts carrying sin-
gle nucleotide polymorphisms in the p57 locus in order 
to examine allele-specific expression during myogenesis 
[17–19]. Cells were infected with a MyoD retroviral vec-
tor and cultured in proliferation medium so as to prevent 
differentiation up to the time of Kcnq1ot1 knockdown. 
After 48 h cells were transfected with Kcnq1ot1 or con-
trol siRNA pools. 24 h later cells were either collected, to 
confirm Kcnq1ot1 downregulation (Fig. 2a) or shifted to 
differentiation medium, to allow the induction of MyoD 
targets. As reported in Additional file 1, Kcnq1ot1 down-
regulation correlates with p57, but not p21 upregulation 
also in MyoD-converted fibroblasts, just like in myo-
blasts. The contribution of the maternal and/or paternal 
alleles to the increase of p57 expression upon Kcnq1ot1 
depletion was investigated by allele-specific RT-qPCR, 
using primers allowing us to measure specifically, as 
well as quantitatively, maternal and paternal p57 mRNA 
levels. As shown in Fig.  2b, the increased levels of p57 
after Kcnq1ot1 depletion are exclusively accounted for 
by the increased expression of maternal p57, and not to 
the re-expression of the imprinted paternal allele. Allele-
specific analysis was also performed by restriction frag-
ment length polymorphism (RFLP) assays. The results 
reported in Additional file 2 confirmed that the increased 
expression of p57 caused by Kcnq1ot1 depletion does not 
involve loss of imprinting. These results indicate that the 
presence of Kcnq1ot1 constrains the expression of mater-
nal p57 during muscle differentiation.
Kcnq1ot1 interacts with a p57 intragenic region 
at both maternal and paternal alleles
The expression of Kcnq1ot1, unlike that of p57 and of the 
co-imprinted gene Kcnq1, does not decrease but, rather, 
slightly increases in differentiating C2.7 muscle cells [18] 
(Additional file 3). This finding rules out a simple model 
where the upregulation of p57 would be linked with a 
differentiation-dependent decline of Kcnq1ot1 expres-
sion. Considering that the activities of LncRNAs are not 
necessarily regulated by their expression levels, but often 
depend on their differential interaction with chromatin 
or with protein complexes, we first explored whether 
Kcnq1ot1 was able to interact with the chromatin at the 
p57 locus.
For this purpose, we performed Chromatin Oligo-affin-
ity Precipitation (ChOP) assays [23] in C2.7 muscle cells. 
We focused our attention not only on p57 promoter, but 
also on an intragenic region located in the second exon of 
the gene (p57i) that, by inspecting the ChIP-seq data for 
muscle cells from ENCODE/Caltech, showed increased 
levels of histone H3 acetylation upon differentiation, 
suggesting its potential regulatory role. Kcnq1ot1 RNA-
associated-chromatin was affinity-purified using either 
a biotin-labeled antisense oligonucleotide against the 
Kcnq1ot1 transcript or a biotin-labeled scrambled oli-
gonucleotide as a control. qPCR analysis was performed 
Fig. 2 Kcnq1ot1 knockdown affects maternal but not paternal p57 expression. a Polymorphic fibroblasts (C57B/6 female × SD7 male) infected with 
the MyoD retroviral vector were transfected with Kcnq1ot1 or control siRNAs. After 24 h, cells were collected to analyze Kcnq1ot1 levels by RT-qPCR 
in samples depleted for Kcnq1ot1 transcript (siKcnq1ot1) compared to the control (siCTR). Values, relative to those of Tbp RNA, are the mean ± SEM 
of three independent experiments. Statistical significance: p value < 0.001 (***); b Allele-specific RT-qPCR analysis of p57 (M-p57: Maternal p57; P-p57: 
Paternal p57) expression was performed in siCTR and siKcnq1ot1 samples using allele-specific primers. Values, relative to those of Tbp RNA, are the 
mean ±SEM of three independent experiments. Statistical significance: p value < 0.01 (**)
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on purified DNA samples using primers correspond-
ing to the regions of interest as outlined in Fig.  3a. As 
expected, and as shown in Fig. 3b, we observed that Kcn-
q1ot1 interacts with the KvDMR1 region from which it 
is transcribed. Remarkably, as reported in the same fig-
ure, we also found a significant interaction of Kcnq1ot1 
with the p57i. Some enrichment, although not statisti-
cally significant, was also detectable for p57 promoter. 
In contrast, no enrichment was observed for the pro-
moter of Nap1l4 (Nucleosome Assembly Protein 1 Like 4), 
which maps nearby the imprinting domain, about 90 kb 
upstream of p57, nor for the promoter of Dppa2 (Devel-
opmental pluripotency associated 2), which is located on 
chromosome 16. To discriminate the allele-specific inter-
actions of Kcnq1ot1 with KvDMR1 and with the p57i, 
we performed ChOP assays in polymorphic fibroblasts 
expressing MyoD, using allele-specific primers for qPCR 
analysis. As shown in Fig.  3c, the Kcnq1ot1 interaction 
with KvDMR1 occurs only at the paternal allele, as previ-
ously reported [32]. Remarkably, unlike for KvDMR1, the 
interaction of Kcnq1ot1 with the p57i region occurs not 
only at the paternal allele, as it would have been expected, 
but also at the maternal counterpart.
As mentioned above, Kcnq1ot1 is thought to be 
expressed from the paternal allele and to act in cis on 
the same chromosome from which it is transcribed, in 
order to silence imprinted genes. Therefore, it was sur-
prising to observe that Kcnq1ot1 physically interacts 
with the maternal p57i and that its knockdown affects 
the expression of maternal p57. We asked whether these 
findings indicated a trans-effect of paternally expressed 
Kcnq1ot1 on maternal p57 regulatory region, or reflected 
the occurrence of maternal Kcnq1ot1 expression, due to 
relaxation of imprinting in muscle cells. To address this 
issue, polymorphic fibroblasts expressing exogenous 
MyoD were analyzed for the relative amounts of maternal 
Fig. 3 Kcnq1ot1 constitutively interacts with an intragenic region of the maternal p57 allele. a Schematic representation of the p57 gene; black 
blocks represent exons, black lines introns and gray boxes the regions analyzed for Kcnq1ot1 binding; p57 p indicates the p57 promoter and 
p57i the p57 intragenic region. b ChOP assays performed in undifferentiated and differentiated C2.7 muscle cells; qPCR analysis of purified DNA 
performed using primers specific for p57 p, p57i and KvDMR1. Dppa2 and Nap1l4 were used as negative controls. The enrichment with antisense 
oligonucleotides over scrambled oligonucleotides was plotted in logarithmic scale. Data represent the mean ± SEM of three independent 
experiments. Statistical significance: p < 0.05 (*). c ChOP assays performed in polymorphic fibroblasts (C57B/6 female × SD7 male); qPCR analysis 
of purified DNA was performed using allele-specific primers for KvDMR1 (M-KvDMR1: Maternal KvDMR1; P-KvDMR1: Paternal KvDMR1) and p57i 
(M-p57i: Maternal p57i; P-p57i: Paternal p57i). Values represent one of two independent experiments, and error bars represent the mean ± SEM of 
each sample analyzed in triplicate
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and paternal Kcnq1ot1 transcripts, by allele-specific 
RT-qPCR. As reported in Fig. 4, Kcnq1ot1 expression is 
restricted exclusively to the paternal allele both in undif-
ferentiated and in differentiated cells.
These and the above results, taken together, suggested 
that the Kcnq1ot1-associated intragenic region is a novel 
regulatory element affecting the functional p57 allele 
in muscle cells through a mechanism involving a trans-
effect of Kcnq1ot1 (see Discussion).
Kcnq1ot1 mediates the accumulation of EZH2 
and H3K27me3 at the p57 intragenic region 
in undifferentiated cells
Since the interaction of Kcnq1ot1 with the p57i occurs 
both in undifferentiated and differentiated cells (Fig. 3b), 
we supposed that the LncRNA could function as a 
molecular scaffold modulating the targeting of repressive 
histone modifications to the maternal allele during differ-
entiation. As mentioned above, Kcnq1ot1 interacts with 
several histone and DNA methyltransferases to estab-
lish the silencing of the p57 domain during imprinting. 
In light of several studies showing that p57 is a target of 
EZH2, the PRC2 catalytic subunit, in different cancer cell 
types [41–43] and in differentiating Schwann cells [44], 
we focused our attention on the tri-methylation of lysine 
27 in histone H3 (H3K27me3), the modification cata-
lyzed by this complex.
To explore the possible role of PRC2 activity in the 
Kcnq1ot1-dependent regulation of maternal p57, we 
first performed ChIP assays for EZH2 and for the 
H3K27me3 mark, indicative of EZH2 activity, using 
polymorphic fibroblasts. qPCR analysis was per-
formed with primers specific for p57 promoter and 
for the maternal and paternal p57 intragenic regions. 
Interestingly, as shown in Fig.  5, EZH2, as well as 
H3K27me3, are associated not only with p57 promoter, 
as previously reported [25, 26, 43, 44] but also, and even 
more significantly, with p57i. Remarkably, the accumu-
lation of EZH2 and H3K27me3 on this region concerns 
almost exclusively the maternal allele. The presence of 
lower levels of H3K27me3 at the paternal p57 allele, 
which is silenced, compared to the maternal p57 allele, 
which is active, at first sight appears as an inconsistency. 
However, several lines of evidence indicate that it is 
DNA methylation that plays the main role in the main-
tenance of p57 imprinting [45–47]. Accordingly, we 
found that the paternal p57i is significantly hypermeth-
ylated with respect to the maternal counterpart (Addi-
tional file  4). Moreover, the maternal intragenic region 
shows the simultaneous presence of H3K27me3 (Fig. 5) 
and histone H3 lysine 4 tri-methylation (H3K4me3) 
(Additional file 4), a chromatin profile frequently associ-
ated with intragenic CpG islands of inducible genes [48].
To prove our starting hypothesis that the EZH2-medi-
ated association of H3K27me3 with the p57i requires 
the presence of Kcnq1ot1 as a scaffold and/or guide, we 
performed ChIP assays in C2.7 muscle cells after deple-
tion of the Kcnq1ot1 transcript. Proliferating myoblasts 
were transfected with Kcnq1ot1 small-interfering RNAs 
as described above and the depletion of the LncRNA 
was verified through RT-qPCR analysis as reported in 
Additional file  5. As shown in Fig.  6a, the reduction of 
Kcnq1ot1 levels correlates with a significant reduction of 
EZH2 association with the p57i, but not with β-globin, 
albumin nor p57 promoters. A parallel decrease, modest 
but statistically significant, was observed for H3K27me3 
levels at p57i. A slight reduction of the histone modifi-
cation was also detectable at p57 promoter but, due to 
a large variability between experiments, did not result 
statistically significant. A similar loss of H3K27me3 
accumulation at the p57i was observed after Knq1ot1 
depletion in polymorphic fibroblasts (Additional file 6). 
These findings support the conclusion that the Kcn-
q1ot1-dependent recruitment of EZH2 promotes the 
repressive histone modification at the p57i.
Of note, the association of both EZH2 and H3K27me3 
with the maternal intragenic region but not with p57 pro-
moter, decreases during differentiation (Fig.  5), further 
reinforcing the idea that it is the p57i, more than p57 
promoter, that plays a role in the H3K27me3-mediated 
regulation of p57 during muscle differentiation. The same 
pattern, characterized by the association of H3K27me3 
with the p57i and its decline in parallel with the induc-
tion of p57, occurs in differentiating C2.7 cells (Addi-
tional file 7).
These results, taken together, suggest that Kcn-
q1ot1 participates in the repression of maternal p57 
Fig. 4 Kcnq1ot1 expression is restricted to the paternal allele and 
does not decrease during differentiation. Allele-specific RT-qPCR 
analysis of maternal and paternal Kcnq1ot1 (M-Kcnq1ot1 and 
P-Kcnq1ot1, respectively) performed in polymorphic fibroblasts 
(C57B/6 female × SD7 male) infected with the MyoD retroviral vector 
and analyzed in undifferentiated (U) and differentiated (D) cells. 
Values, normalized to Tbp expression, are the mean ± SEM of four 
independent experiments. Statistical significance: p value < 0.01 (**)
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Fig. 5 EZH2 and H3K27me3 association to the maternal p57 
intragenic region decreases during differentiation. ChIP-qPCR analysis 
for IgG and EZH2 (a) and H3K27me3 (b) during differentiation (U 
undifferentiated and D differentiated) of polymorphic fibroblasts 
(C57B/6 female × SD7 male) expressing exogenous MyoD. qPCR 
analysis was performed using primers specific for p57 promoter 
(p57 p), for maternal and paternal p57 intragenic regions (M-p57i 
and P-p57i, respectively), and for β-Actin promoter (β-Act p) used 
as a negative control. Values are the mean of two independent 
experiments and expressed as percentages of Input. Values for 
H3K27me3 association were also normalized to those of the invariant 
internal control, the Amylase promoter. Error bars indicate the SEM. p 
value < 0.05 (*)
Fig. 6 EZH2 and H3K27me3 association to the p57 intragenic 
region decreases after Kcnq1ot1 depletion. C2.7 myoblasts were 
transfected with Kcnq1ot1 or control siRNAs as in Fig. 1a and 
analyzed by RT-qPCR (Additional file 5) or ChIP-qPCR. a ChIP-qPCR 
analysis for control IgG (upper panel) and for EZH2 binding (lower 
panel) to the p57 promoter (p57 p) and to the p57 intragenic region 
(p57i). β-Globin promoter (β-Glob p) and Albumin promoter (Alb p) 
were used as invariant controls, b ChIP-qPCR analysis of H3K27me3 
association to the p57 promoter (p57 p), p57 intragenic region 
(p57i), β-Globin promoter (β-Glob p) used as an invariant control and 
β-Actin promoter (β-Act p) as a negative control. Values obtained 
are expressed as percentages of Input chromatin and normalized to 
those of Albumin promoter, used as an additional invariant control. 
Results are the mean ± SEM of three independent experiments. 
Statistical significance p value < 0.05 (*)
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expression in undifferentiated muscle cells by influencing 
H3K27me3 accumulation on the p57i and that the induc-
tion of p57 during differentiation correlates with the loss 
of this mark at this newly identified regulatory region.
MyoD binds to the maternal p57 intragenic region 
and interacts with Kcnq1ot1 in differentiated cells
It has been previously reported that EZH2 represses 
muscle differentiation at least in part by counteract-
ing MyoD binding, via H3K27me3 accumulation, to 
muscle-specific gene promoters [49]. Using MatInspec-
tor software to scan putative MyoD-binding sites within 
the p57 gene, we detected the presence of two adjacent 
canonical E-box sites, just in the intragenic region that 
we have found to be bound by Kcnq1ot1 and by EZH2. 
To assess the interaction of MyoD with chromatin at 
this region, we performed ChIP assays in C2.7 muscle 
cells during differentiation. The results were analyzed 
by qPCR using primers surrounding the putative MyoD-
binding sites at the p57i or targeted to p57 promoter, 
where we had previously demonstrated that MyoD does 
not bind [18]. As shown in Fig. 7a, MyoD interacts with 
the p57i and not, as expected, with p57 promoter. More-
over, although MyoD is also expressed in undifferenti-
ated cells [50–52], this interaction takes place only after 
differentiation, just like we observed for the promoter 
of Myogenin, a muscle-specific MyoD target [53]. In 
order to determine the allele-specificity of MyoD bind-
ing, we performed ChIP assays in polymorphic fibro-
blasts expressing the myogenic factor and analyzed the 
Fig. 7 MyoD binds to the maternal p57 intragenic region upon differentiation. a ChIP-qPCR analysis of MyoD binding in undifferentiated (U) and 
differentiated (D) C2.7 muscle cells using primers for p57 promoter (p57 p) and p57 intragenic region (p57i) (left) and for Myogenin promoter (MyoG 
p) (right) used as a positive control for MyoD binding during differentiation. b Allele-specific ChIP-qPCR of MyoD binding in polymorphic fibroblasts 
(C57B/6 female × SD7 male) expressing exogenous MyoD in undifferentiated (U) and differentiated (D) cells, using primers specific for p57 promoter 
(p57 p), for maternal and paternal p57 intragenic regions (M-p57i and P-p57i, respectively) and for Myogenin promoter (MyoG p). Values were 
expressed as percentages of Input and error bars indicate SEM of three independent experiments performed, excepted for the part B-left of the 
figure in which values are the mean ± SEM of four independent experiments. Statistical significance: p value < 0.05 (*) and < 0.01 (**)
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MyoD-immunoprecipitated chromatin through allele-
specific qPCR. Remarkably, as shown in Fig.  7b, MyoD 
binding occurs only to the maternal allele of the p57i and, 
also in this case, only in differentiated cells. The recruit-
ment of MyoD to the maternal allele upon differentiation 
reflects exactly the loss of EZH2 and H3K27me3 from the 
same region. On the other hand, the inability of MyoD 
to bind to the paternal p57i, where H3K27me3 levels are 
constitutively low, is likely a consequence of the allele-
specific DNA hypermethylation of the region (Additional 
file 4) which renders the E-boxes permanently inaccessi-
ble to transcription factor binding.
Although the decrease in EZH2 interaction with p57i 
could be explained by the reduction of the enzyme lev-
els known to occur during muscle differentiation [49, 
54], we noticed that EZH2 binding is maintained at p57 
promoter, where MyoD does not bind. The observation 
that the binding of MyoD and EZH2 to p57i are mutu-
ally exclusive raises the suggestion that MyoD itself may 
play a direct role in EZH2 dynamics at this region. It has 
been previously shown that MyoD is capable to func-
tionally interact with ribonucleoprotein complexes, as 
demonstrated for the non-coding RNA steroid receptor 
activator SRA [55] and for the muscle-specific LncRNA 
Linc-RAM [56]. To verify whether MyoD physically inter-
acts with Kcnq1ot1 during differentiation, we performed 
RNA immunoprecipitation (RIP) assays for MyoD as well 
as for EZH2. The amount of Kcnq1ot1 transcript asso-
ciated with either protein was analyzed by RT-qPCR. 
As shown in Fig. 8, and as already observed in placenta, 
EZH2 interacts with Kcnq1ot1. However, this interac-
tion, unlike we observed for HOTAIR, another LncRNA 
known to associate with EZH2 [57], decreases upon dif-
ferentiation. In contrast, MyoD specifically interacts with 
Kcnq1ot1, but not with HOTAIR, and only in differenti-
ated cells. The specificity of the interaction between Kcn-
q1ot1 and MyoD was further verified by an additional 
RIP assay for the histone demethylase LSD1/KDM1A, 
known to interact with HOTAIR but not with Kcnq1ot1 
[31, 58]. As shown in Additional file  8, the result con-
firmed that even in differentiated C2 cells, HOTAIR, but 
not Kcnq1ot1, co-immunoprecipitates with LSD1. These 
findings insinuate that MyoD, by interacting with Kcn-
q1ot1 at the maternal intragenic region, could interfere 
with EZH2 binding, therefore contributing to the chro-
matin changes that promote p57 upregulation.
Discussion
Kcnq1ot1 is a well-recognized player of the machinery 
that participates in the silencing of paternal p57 during 
imprinting. The present work suggests that Kcnq1ot1, 
similarly to CTCF and KvDMR1, exerts a repressive 
function also on maternal p57, highlighting an addi-
tional and unexpected level of p57 regulation in muscle 
cells. It is important to notice that in this experimental 
setting Kcnq1ot1 depletion leads to the upregulation of 
the maternal active allele but not to the re-expression 
of the paternal imprinted allele. A possible explanation 
for the maintenance of imprinting after siRNA treat-
ment could be that the transcriptional silencing and the 
stable repression of the paternal Cdkn1c/Kcnq1 locus is 
reinforced by the cooperation of more than one silencing 
mechanism. In fact, the establishment and maintenance 
of the imprinting involve not only the Kcnq1ot1-medi-
ated recruitment of repressive chromatin modifiers, but 
also the CTCF-mediated enhancer-blocking activity 
and the chromatin looping. Moreover, despite most evi-
dence suggests that Kcnq1ot1 exerts the silencing activity 
through its RNA product [23, 36, 59], some results sup-
port a model in which it is the act of Kcnq1ot1 transcrip-
tion, preserved in knockdown assays, and not the RNA 
product per se, that plays a role in the imprinting process 
[60]. Consistent with our finding, it was reported that the 
depletion of Kcnq1ot1, through short hairpin RNAs, did 
not cause loss of imprinting in mouse stem cells [36].
Another interesting question raised by our results 
is how Kcnq1ot1, which is assumed to be paternally 
expressed in every tissue and to act in cis, can regulate 
maternal p57. A maternal Kcnq1ot1 isoform, initiated 
from an alternative promoter located downstream of the 
hypermethylated CpG island, and thus escaping silenc-
ing, was described in heart tissue [61]. However, this 
isoform did not affect maternal p57 expression, probably 
because it is non-functional due to the lack of the silenc-
ing domain, located at the 5′ of the transcript. Although 
it is possible that some maternally expressed isoform 
exists also in muscle cells, the location of the primers 
we used for allele-specific analysis, allows us to exclude 
the presence of maternal Kcnq1ot1 transcripts including 
the silencing domain, both in undifferentiated and dif-
ferentiated cells. An additional and attractive hypothesis 
is that paternal Kcnq1ot1 could interact with and regu-
late maternal p57 through a mechanism involving allele 
proximity. In this regard, homologous pairing in somatic 
cells has emerged as a phenomenon more widespread 
than previously believed [62, 63]. Remarkably, one of the 
chromosomal regions that were reported to undergo fre-
quent pairing in embryonic stem cells is just the Cdkn1c/
Kcnq1 domain [63]. The significance of allelic interac-
tions in gene regulation, as well as how the homologous 
regions come together, has not been established yet. 
However, it is reasonable to expect that the allele proxim-
ity creates the opportunity for several types of trans-reg-
ulatory interactions, including those involving cis-acting 
LncRNAs.
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Regardless of the in cis or in trans activity, the results 
obtained by ChOP assays prove that Kcnq1ot1 interacts 
with chromatin at an intragenic region of p57, not only 
on the paternal but also on the maternal allele. Impor-
tantly, an evident accumulation of EZH2 and H3K27me3 
is present at the same region, in particular on the mater-
nal allele. The observation that the levels of EZH2 and 
H3K27me3 at this region decrease after Kcnq1ot1 deple-
tion supports the conclusion that the LncRNA plays an 
important role in directing the chromatin modifica-
tion. These results suggest that a functional interaction 
between Kcnq1ot1 and PRC2 at the maternal p57 gene, 
and in particular at the intragenic region, participates in 
the repression of p57 expression in muscle cells. Histone 
and DNA modifications are well characterized for their 
regulatory effects on promoter and enhancer regions. 
However, also gene bodies seem to be the target of epige-
netic modifications, even though their function remains 
unclear. It is commonly believed that repressive modi-
fications, in particular DNA methylation, at intragenic 
regulatory elements may serve to prevent the occur-
rence of transcription initiation from non-canonical 
promoters [64]. More recently, some evidence is emerg-
ing that epigenetic modifications at intragenic elements 
can affect the arrest or release of transcriptional elon-
gation, in this way regulating total mRNA levels and/or 
alternative splicing through a co-transcriptional mecha-
nism [65, 66]. Interestingly, it has been reported that the 
decrease in H3K27me3 at some intragenic regions of 
the muscle-specific genes Myogenin and Muscle creatine 
kinase [67] and of a number transforming growth fac-
tor β-responsive genes [68] are functionally correlated 
with the progression of RNA polymerase II through their 
gene bodies and with their increased expression. Previ-
ous results from our laboratory, based on Norther blot, 
RT-PCR and Western blot analysis, would suggest that 
the upregulation and downregulation of p57 in mus-
cle cells concern a single and canonical isoform of p57 
mRNA, thus rendering unlikely that the accumulation of 
H3K27me3 at the newly identified regulatory region may 
act by causing the arrest of transcriptional elongation or 
by promoting an alternative splicing event. More work is 
required not only to definitively clarify this point but also 
to determine whether the p57i may nucleate additional 
epigenetic modifications and/or promote changes of the 
three-dimensional architecture of the locus, resulting in 
transcriptional repression.
Importantly, Kcnq1ot1 remains bound to p57i, while 
EZH2 and H3K27 levels decrease upon differentia-
tion stimuli, suggesting that the scaffold function of the 
LncRNA is modulated during differentiation. A dynamic 
association of Kcnq1ot1 with its interacting partners has 
been previously proposed to explain the lineage-specific 
silencing of some imprinted genes [23]. Remarkably, 
MyoD binding occurs to the same p57i bound by Kcn-
q1ot1, but only after differentiation. The simplest inter-
pretation of these results is that the decrease in EZH2 
levels in differentiated cells accounts for the decreased 
H3K27me3 accumulation, the increased MyoD binding 
to the E-boxes, and the consequent recruitment of the 
multiple chromatin modifiers and remodelers engaged by 
MyoD [69] (see the model depicted in Fig. 9). However, 
our observation that during differentiation EZH2 lev-
els do not decrease at p57 promoter, where MyoD does 
not bind, could indicate that MyoD and EZH2 mutually 
interfere with each other at p57i. A suggestive hypothesis 
is that MyoD, by physically interacting with Kcnq1ot1, 
may induce a conformational change of the LncRNA, 
which could reduce its affinity for EZH2, resulting in the 
release of repression. The involvement of both ubiquitous 
Fig. 8 Kcnq1ot1 interacts with EZH2 in undifferentiated and with MyoD in differentiated cells. Cell extracts of undifferentiated (U) and differentiated 
(D) C2.7 muscle cells were immunoprecipitated using anti-EZH2 or anti-MyoD antibodies. The immunopurified materials were subjected to RT-qPCR 
with specific primers for Kcnq1ot1 and HOTAIR transcripts. Values, relative to the mean of three and four independent experiments performed for 
EZH2 and MyoD, respectively, were expressed as fold enrichment respect to IgG. Statistical significance: p < 0.05 (*)
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and muscle-specific LncRNAs, in the processes of skel-
etal muscle differentiation and regeneration, is becom-
ing increasingly evident [70–72]. However, the precise 
function of these LncRNAs in gene regulation is not yet 
completely clear. The ability of MyoD to interact with 
regulatory non-coding RNAs, as reported for SRA and 
Linc-RAM in previous works [55, 56] and as shown for 
Kcnq1ot1 in the present one, could represent a more 
widespread phenomenon in the strategy by which the 
myogenic factor controls muscle differentiation, expand-
ing our understanding of the biology of LncRNAs in the 
muscle system.
It is worth mentioning that Kcnq1ot1 is over-expressed 
in different cancer types, such as colorectal carci-
noma [73], glioma [37], lung adenocarcinoma [38] and 
hepatoma [74]. Moreover, the knockdown of Kcnq1ot1 
exerts a tumor-suppressive effect in some of these can-
cers [37, 38]. How increased Kcnq1ot1 levels contribute 
to carcinogenesis is still unknown but it is plausible that 
the oncogenic function of the LncRNA is mediated, at 
least in part, by the repression of the maternal p57 allele, 
frequently silenced in cancer cells. It is important to 
point up that, in colorectal cancer cell lines, Kcnq1ot1 is 
monoallelically over-expressed [73], thus indicating that 
the observed effects do not result from loss of imprinting, 
but instead, may involve a functional interaction between 
Kcnq1ot1 and p57 similar to the one that we have high-
lighted in muscle cells.
Conclusions
In summary, this work not only highlights an additional 
mechanism involved in fine tuning the expression of p57 
during muscle differentiation and, possibly in other phys-
iological and pathological processes, but also discloses an 
imprinting-independent function of Kcnq1ot1, aimed at 
regulating the maternal, non-imprinted p57 allele. More-
over, it reveals that Kcnq1ot1 functionally interacts with 
a tissue-specific member of the bHLH family of tran-
scription factors, adding new insight into the regulatory 
potential of such a mysterious LncRNA.
A more detailed knowledge of the complex roles of 
Kcnq1ot1 and of chromatin modifications at the mul-
tiple p57 regulatory regions not only will further clarify 
the molecular mechanisms underlying the tight and fine 
regulation of p57 expression in developing tissues and its 
silencing in over-growth diseases and cancer, but also will 
provide a tool for devising strategies aimed at restoring 
the expression of the CDK inhibitor.
Fig. 9 Schematic model of the mechanism by which Kcnq1ot1 regulates p57 expression during muscle differentiation. In undifferentiated cells 
Kcnq1ot1 recruits EZH2 and promotes H3K27me3 accumulation on the p57 intragenic region (p57i). Upon differentiation stimuli, the decrease in 
EZH2 binding and H3K27me3 levels allows the interaction of MyoD and, conceivably, other cofactors with the same region and with Kcnq1ot1, 
leading to the induction of p57 expression
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Methods
Cell cultures
Mouse polymorphic fibroblasts (C57BL/6 × SD7) and 
C2.7 muscle cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) (Gibco) supplemented with 
10% fetal bovine serum (FBS) (Gibco). To induce MyoD 
activity and differentiation, cells were shifted to differen-
tiation medium (DMEM supplemented with 0.5% FBS) 
and collected 24 or 48  h later, as indicated. Production 
of MyoD-expressing retrovirus and retroviral infections 
were performed as previously described.
ChIP assays
ChIP assays were carried out as previously described 
using 150  µg of chromatin for EZH2 and MyoD, and 
50 µg of chromatin for modified histones. In brief, chro-
matins were immunoprecipitated with anti-MyoD anti-
body ([sc-760] Santa Cruz Biotechnology), anti-EZH2 
antibody (39901, Active Motif ), anti trimethyl-histone 
H3K27 (07-449, Millipore), anti trimethyl-histone H3K4 
(07-473, Millipore), normal rabbit (Millipore, 12-370) or 
normal mouse IgG (Millipore, 12-371). qPCR analysis 
was performed in triplicate for each of three independent 
experiments, using 5 ng of DNA, Go Taq qPCR Master 
Mix (Promega) and the following primer pairs:
p57 prom  F: 5′5′ACT GAG AGC-AAG CGA ACAGG-3′
  R: 5′ACC TGG CTG ATT GGT GAT GG-3′;
Maternal p57i  F: 5′-CAG ATC TGA CCT CAG ACC CA-3′
  R: 5′-CCT GTT CCT CGC CGT CCC -3′;
Paternal p57i  F: 5′CAG ATC TGA CCT CAG ACC CG-3′
  R: 5′-GAC CTG TTC CTC GCC ATC CT-3′;
β-globin prom  F: 5′-GAA GCC TGA TTC CGT AGA GC-3′
  R: 5′-CAA CTG ATC CTA CCT CAC CTT ATA 
TGC-3′;
β-Actin prom  F: 5′-GTG ACA TCC ACA CCC AGA GG-3′
  R: 5′-GAA TAG CCT CCG CCC TTG -3′;
Amylase prom  F: 5′-TCA GAT GGG AGG ACT GCT ATTGT-3′
  R: 5′-GCT CAC ATT CCT TGG CAA TATCA-3′;
Albumin prom  F: 5′-AAT CGT CTT TGA GGC ACC AG-3′
  R: 5′-GCT CAA TCT TCC CAA ACA GG-3′;
Timm prom  F: 5′-ACG GAT GTG GCC CTT CTG GCT-3′
  R: 5′-CCG CTG CGA AAC GCC CAC AA-3′;
p57i  F: 5′-AAC TTC CAG CAG GAT GTG CC-3′
  R: 5′-CAT CCA CTG CAG ACG ACC AG-3′
Gene expression analysis
Total RNA was extracted using the High Pure RNA Iso-
lation Kit (Roche) and 1 µg of total RNA was reverse-
transcribed using the iScript cDNA Synthesis Kit 
(Bio-Rad). cDNA obtained was diluted and analyzed 
through qPCR using the following sets of primers:
p57  F: 5′-AAC TTC CAG CAG GAT GTG 
CC-3′
  R: 5′-CAT CCA CTG CAG ACG ACC 
AG-3′
Myogenin  F: 5′-GTC TCT TCC TGA AGC CAG 
TTGCG-3′
  R: 5′-TGC AAA TGC TTG GCC CCC 
AGAG-3′
Kcnq1ot1  F: 5′-TTC TGG AGG CGA TTG AGG 
C-3′
  R: 5′-AGC AAC CAG AAC CAG GTG 
AGAG-3′
Maternal p57  F: 5′-CAG ATC TGA CCT CAG ACC 
CA-3′
  R: 5′-CCT GTT CCT CGC CGT CCC 
-3′
Paternal p57  F: 5′CAG ATC TGA CCT CAG ACC 
CG-3′
  R: 5′-GAC CTG TTC CTC GCC 
ATC CT-3′
Maternal Kcnq1ot1  F: 5′-ACT CGG AAT TCA GGT GTG 
GG-3′
  R: 5′-GGT TGG AGG TCA CCA CAA 
CAT-3′
Paternal Kcnq1ot1  F: 5′-ACT CGG AAT TCA GGT GTG 
GA-3′
  R: 5′-GGT TGG AGG TCA CTA CAA 
CAT-3′
p21  F: 5′-TGG ACA TGG TGC CTG TGG 
CTCT-3′
  R: 5′-AGC AGC CGA GAG GTG TGA 
GC-3′
Kcnq1  F: 5′-TGA GAA AGA TGC GGT GAA 
CG-3′
  R: 5′-GCG TAG CTG CCA AAC TCG 
AT-3′
Tbp  F: 5′-GGC GGT TTG GCT AGG TTT 
-3′
  R: 5′-GGG TTA TCT TCA CAC ACC 
ATG-3
RNA interference
8 × 105 C2.7 muscle cells were transfected using a mix-
ture of four chemically synthesized siRNAs duplexes 
(Kcnq1ot1 MOUSE SMARTpool Dharmacon) and with 
a non-targeting pool (Lincode Non-targeting Control 
siRNAs Dharmacon) as negative control, at a final con-
centration of 100  nM. Kcnq1ot1 expression levels were 
analyzed 24  h after transfection in proliferation condi-
tions, while 24  h after the shift to differentiation con-
ditions (DMEM containing 0.5% FCS) samples were 
collected to analyze p57 and p21 expression levels.
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Polymorphic fibroblasts (C57BL/6 × SD7) expressing 
MyoD were transfected 48 h after infection, with 200 nM 
siRNAs. Samples were collected 24  h after transfection 
to check the reduction of Kcnq1ot1 expression and 24 h 
after the shift to differentiation medium to determine 
p57 and p21 expression levels.
ChOP assays
ChOP assays were carried out according to the pub-
lished protocol [23, 75] with some modifications. In 
brief, approximately 10 × 106 cells were fixed with 1% 
formaldehyde for 10 min at 37 °C. Glycine was added to 
a final concentration of 0,125 M in phosphate-buffered 
saline (PBS) for 5 min at 4 °C and 5 min at room tem-
perature with gentle shaking. Cells were washed with 
cold PBS, scraped and nuclei were isolated in buffer A 
(3 mM MgCl2, 10 mM Tris–Hcl (pH 7.4), 10 mM NaCl, 
and 0.5% NP-40). After centrifugation and washing 
once in an equal volume of buffer A, nuclei were lysed 
in buffer B (50 mM Tris–HCl [pH 7.9], 10 mM EDTA, 
0,2  mM PMSF, 1%SDS, supplemented with protease 
inhibitors and 100 U/ml RNase inhibitor), and incu-
bated on ice for 10  min. An equal volume of buffer C 
(15  mM Tris–HCl [pH 7.9], 150  mM NaCl, 1  mM 
EDTA, 1% Triton-X-100, 0,2  mM PMSF, protease and 
RNase inhibitors) was added, and nuclear chromatin 
was sonicated to obtain fragment sizes ranging from 
300 to 700 bp in length. Chromatin was quantified for 
DNA, and 150 μg aliquots were prepared for each sam-
ple. Protein A Sepharose was blocked in an equal vol-
ume of buffer D (15  mM Tris–HCl [pH 7.9], 150  mM 
NaCl, 1  mM EDTA, 0,5% NP-40, 0,2  mM PMSF and 
proteinase inhibitors) containing 400μg/ml yeast RNA 
and 800 μg/ml of bovine serum albumin (BSA) for 4 h. 
Beads were washed three times with buffer D and incu-
bated overnight at 4  °C with 5 μg of anti-biotin anti-
body (ab66-43-100, Abcam). The sonicated chromatin 
was incubated overnight at 4  °C with 25  pmol of bio-
tin-labeled oligo antisense to Kcnq1ot1 (biotin 5′-CCA 
AAA GAA CTG TGG ACA AAT ATG CTG AGG CTG-3′), 
or biotin-labeled Scrambled oligo (biotin 5′-GCC AAG 
TGT TAA AGG CCA AAC TAC GTT GAG AGA-3′), and 
incubated overnight at 4 °C. 50 μl of beads with bound 
antibody was added to samples containing the oligonu-
cleotides and incubated for 4 h at 4 °C. Before washing, 
the supernatant of the scrambled samples was taken 
as Input. Each sample was washed twice with Low Salt 
buffer (SDS 0.1%, Triton-X-100, EDTA 2 mM, Tris–HCl 
20  mM pH = 8.1, NaCl 150  mM) and with High Salt 
buffer (SDS 0.1%, Triton-X-100, EDTA 2 mM, Tris–HCl 
20  mM pH = 8.1, NaCl 500  mM); once time with LiC 
Buffer (LiCl 0,25 M, NP40 1%, deoxycholate 1%, EDTA 
1 mM, Tris–HCl10 mM pH = 8,1) and TE Buffer (Tris-
HCl 10 mM, EDTA 1 mM pH = 8). Samples were eluted 
with 300μl of Elution Buffer (TE 1x, SDS 0.5%), treated 
with 1 μg of RNAse A (Sigma-Aldrich) for 10  min at 
room temperature and with and 240 μg of Protein-
ase K (Sigma-Aldrich) for 5  h at 62  °C. The DNA was 
extracted with phenol–chloroform, precipitated with 
isopropanol and re-suspended in 50  μl of nuclease-
free water (Promega). After the immunoprecipitation, 
the DNA concentration of each sample was measured. 
The enrichment of Kcnq1ot1-interacting genomic DNA 
regions was analyzed by qPCR using the following 
primers:
Maternal KvDMR1  F: 5′-ACT CGG AAT TCA GGT GTG 
GG-3′
  R: 5′-GGT TGG AGG TCA CCA CAA 
CAT-3′
Paternal KvDMR1  F: 5′-ACT CGG AAT TCA GGT GTG 
GA-3′
  R: 5′-GGT TGG AGG TCA CTA CAA 
CAT-3′
p57 promoter  F: 5′-ACT GAG AGC-AAG CGA A 
CAGG-3′
  R: 5′-ACC TGG CTG ATT GGT GAT 
GG-3′
KvDMR1  F: 5′-GCA CAA GTC GCA AGT CCG 
CG-3′
  R: 5′-ATG GAG CCC AGC CGC GAA 
AG-3′
Maternal p57i  F: 5′-CAG ATC TGA CCT CAG ACC 
CA-3′
  R: 5′-GAC CTG TTC CTC GCC ATC 
CT-3′
Paternal p57i  F: 5′AAC TTC CAG CAG GAT GTG 
CC-3′
  R: 5′-GAC CTG TTC CTC GCC ATC 
CT-3′
p57i  F: 5′-AAC TTC CAG CAG GAT GTG 
CC-3′
  R: 5′-CAT CCA CTG CAG ACG ACC 
AG-3′
Dppa2 prom  F: 5′-TGC CCT GGA TTT AAA ACG 
TC-3′
  R: 5′-CGA GCT TTG TCC TCC TGG 
TA-3′
Nap1l4 prom  F: 5′-AGG TGT TGG GAT TGA AGG 
TG-3′
  R: 5′-CAC CCA ATA CAA AGG CTG 
CT-3′
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RIP assays
Undifferentiated and differentiated C2.7 muscle cells 
were harvested in PBS supplemented with 0,2 mM PMSF. 
Nuclei were isolated with buffer A (20  mM Tris–HCl 
[pH 8.0], 10  mM NaCl, 3  mM MgCl2, 0,1% NP40, 10% 
glycerol, 0,2 mM EDTA, with 0,4 mM PMSH, proteinase 
inhibitors and RNAse Inhibitors [100U/μl]), incubated at 
4  °C for 30 min. Nuclei were extracted with NT2 buffer 
(50 mM Tris–HCl [pH 7.4], 150 mM NaCl, 1 mM MgCl2, 
0,5% NP-40, 20 mM EDTA, 0,4 mM PMSF, 1 mM DTT, 
and proteinase and RNase Inhibitors). Nuclear protein 
extracts were quantified and 1,5 mg of protein were used 
for each sample. 100μl of protein A Sepharose were incu-
bated with 5 μg of anti-MyoD antibody (sc-760, Santa 
Cruz), anti-EZH2 antibody(39901, Active Motif ), anti-
LSD1 antibody (ab 17721 Abcam), normal rabbit IgG 
([12-370] Merk Millipore) or normal mouse IgG ([12-
371] Merk Millipore) for 6 h at 4 °C. Lysate pre-clearing 
was performed using 150μl of protein A Sepharose and 
keeping samples for 6  h at 4  °C. 100 μl of beads with 
bound antibody were added to pre-cleared samples and 
incubated overnight at 4  °C. Before washing, the super-
natant of the IgG sample was taken as Input. Each sample 
was washed four times with 500 μl of NT2 buffer, treated 
with 10U of DNase (Roche), RNA was extracted with Tri-
zol Reagent (Invitrogen) and precipitated overnight with 
isopropanol. RNA was re-suspended in 25 μl of nuclease-
free water (Promega), and Kcnq1ot1 enrichment was 
analyzed by RT-qPCR using the following primers:
Kcnq1ot1  F: 5′-TTC TGG AGG CGA TTG AGG C-3′
  R: 5′-AGC AAC CAG AAC CAG GTG AGAG-3′
HOTAIR  F: 5′-GCG CCA ACG TAG ACC AAA AG-3′
  R: 5′-TAC CGA TGT TGG GGA CCT CT-3′
Statistical analysis
For statistical analysis, comparisons were performed 
using parametric paired Student’s t test. Statistical signifi-
cance is shown as p < 0.05 (*) or p < 0.01 (**) or p < 0.001 
(***).
Additional files
Additional file 1. Kcnq1ot1 knockdown boosts p57 induction in MyoD-
converted fibroblasts. Polymorphic fibroblasts (C57B/6 female × SD7 male) 
infected with the MyoD retroviral vector were transfected with Kcnq1ot1 
or control siRNAs and analyzed by RT-qPCR for p57 and p21 expres-
sion 24 h after the shift to differentiation medium. Values, relative to those 
of Tbp RNA, are the mean ± SEM of three independent experiments. 
Statistical significance: p value < 0.05 (*).
Additional file 2. Kcnq1ot1 knockdown affects maternal but not paternal 
p57 expression. RNAs from siCTR and siKcnq1ot1 samples (prepared as 
described in Additional file 1) were amplified by RT-PCR with primers 
surrounding the single nucleotide polymorphism. Maternal and paternal 
cDNAs were distinguished by RFLP analysis of previously described poly-
morphic restriction sites; ND (Non-digested samples) indicates the elec-
trophoretic mobility of the undigested p57 paternal-specific amplicon, 
while AVA I indicates the electrophoretic mobilities of the AVA I-digested 
maternal-specific fragments; the RFLP analysis shown represents one of 
three independent experiments.
Additional file 3. Kcnq1ot1 expression does not decrease during differ-
entiation. RT-qPCR analysis of Kcnq1ot1, expression in undifferentiated (U) 
and differentiated (D) C2.7 muscle cells; p57 and the muscle-specific gene 
Myogenin (MyoG) were used to follow the differentiation process. Values, 
relative to those of Tbp RNA, are the mean ± SEM of four independent 
experiments. Statistical significance: p value < 0.05 (*); p value < 0.01 (**).
Additional file 4. Differential epigenetic status of the maternal and 
paternal p57 intragenic regions. Left: Allele-specific ChIP-qPCR analysis of 
H3K4me3 accumulation at Maternal and Paternal p57 intragenic regions 
(M-p57i and P-p57i, respectively) in polymorphic fibroblasts; Amylase pro-
moter (Amy p) was used as negative control. Values are the mean ± SEM 
of three independent experiments performed and were expressed as 
percentages of Input. Statistical significance: p value < 0.05 (*). Right: 
qPCR analysis of the MeDIP assays performed in polymorphic fibroblasts 
(C57B/6 female × SD7 male) using allele-specific primers for the p57 
intragenic region (M-p57i and P-p57i, respectively). Translocase of inner 
mitochondrial membrane 17 promoter (Timm p) was used as a negative 
control. The results shown represent one of two independent experiments 
performed. Values were expressed as percentages ± SEM of Input DNA for 
each sample analyzed in triplicate.
Additional file 5. Verification of Kcnq1ot1 depletion in cells used for 
the ChIP assays reported in Fig. 6. C2.7 myoblasts were transfected with 
Kcnq1ot1 siRNAs as in Fig. 1a and analyzed by RT-qPCR for Kcnq1ot1 RNA 
levels in siCTR and siKcnq1ot1 samples. Values were normalized to Tbp 
RNA levels and expressed as percentages of the control. Results are the 
mean ± SEM of three independent experiments. Statistical significance: p 
value < 0.001 (***)
Additional file 6. H3K27me3 association to the p57 intragenic region 
decreases after Kcnq1ot1 depletion. Polymorphic fibroblasts (C57B/6 
female × SD7 male) infected with the MyoD retroviral vector were trans-
fected with Kcnq1ot1 or control siRNAs as in Fig. 2a and analyzed by ChIP-
qPCR for H3K27 association to the maternal p57 intragenic region (M-p57i), 
β-Globin promoter (β-Glob p) used as an invariant control and β-Actin 
promoter (β-Act p) as a negative control. Values obtained are expressed 
as percentages of Input chromatin and normalized to those of Albumin 
promoter, used as an additional invariant control. The results shown 
represent one of two independent experiments and error bars represent 
the mean ± SEM of each sample analyzed in triplicate.
Additional file 7. H3K27me3 association to the p57 intragenic region 
decreases during differentiation. ChIP-qPCR analysis of H3K27me3 associa-
tion to the p57 intragenic region (p57i) and p57 promoter (p57 p) in undif-
ferentiated (U) and differentiated (D) C2.7 muscle cells. β-Actin promoter 
(β-Act p) was used as a negative control. Values obtained were expressed 
as percentages of Input chromatin and normalized to those of Albumin 
promoter, used as an invariant control. The results are the mean ± SEM of 
three independent experiments. Statistical significance: p value < 0.05 (*).
Additional file 8. Kcnq1ot1 and HOTAIR are differentially associated with 
LSD1. Cell extracts of differentiated C2.7 muscle cells were immunoprecip-
itated using anti-LSD1 antibody or control IgG. Immunopurified materials 
were subjected to RT-qPCR with specific primers for Kcnq1ot1 and HOTAIR 
transcripts. Values, relative to a representative experiment, were expressed 
as fold enrichment respect to IgG.
Additional file 9. Additional methods.
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